Business Wire

TC Latin America Partners integrates an industrial investment and development platform in Mexico to strengthen its local presence

Share

International companies are relocating their production and logistics centers to Mexico to strengthen their supply chains in North America and take advantage of geographic benefits and labor costs. According to a survey conducted by Capterra, a subsidiary of consulting firm Gartner, about 88% of small and medium-sized companies in the United States plan to reorganize their supply chains in 2023 to use local or Mexican suppliers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230419005741/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

TC Latin America Partners continues to work on the development of industrial properties in Mexico. (Photo: Business Wire)

In response to the increasing demand for industrial real estate space in Mexico, TC has integrated a development team with extensive experience in the Mexican market into its local operation, to create a comprehensive industrial investment and development platform.

The investment strategy is oriented towards the acquisition and development of Class A industrial properties, with a focus on the development of built-to-suit assets. Gregorio Schneider, founding partner of TC, who has more than 25 years of experience in the sector, will lead the platform together with a team with extensive experience developing and operating industrial assets.

"We are very excited about this platform, which was created to give continuity to the industrial strategy we have been executing in Mexico and the US since 2016. The platform will be led by a team with extensive experience in the local industrial sector, which will become the strategic ally of companies looking for nearshoring solutions in Mexico," said Gregorio Schneider.

Antonio Báez and Raúl Arroyo will lead the areas of investment, acquisition, and project development. Raúl has more than 16 years of experience in the Mexican industrial real estate sector, where he has developed more than 645,000 square meters, and managed approximately 4 million square meters of industrial space. Antonio has more than 15 years of experience in the real estate sector, participating in the development of more than 1.2 million square meters.

"We believe that one of the competitive advantages of this new platform is having an experienced local investment and development team with deep knowledge of the market and long-standing relationships. The participation of Raúl and Antonio in this initiative will be decisive to meet the growth objectives we have set," said Gregorio Schneider.

To date, TC has invested in nine industrial buildings in Mexico, including manufacturing and distribution centers for tenants such as Foxconn, Forvia, and Auto Plastek. The firm plans to continue to expand its industrial strategy thanks to the integration of the platform’s investment and development operations.

This new platform is prepared to lead the market and offer comprehensive solutions for companies looking to expand or relocate their operations in Mexico.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Jeimy De los Santos
contenido@labya.com
+1.809.712.5123
LABYA | Consultoría Estratégica

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Nanochon closes $4M Series Seed Prime6.5.2024 18:00:00 EEST | Press release

Nanochon, a Washington, DC-based orthopedic device biotech company has raised $4 million in its series seed prime fundraising round. The round was led by The University of Virginia Licensing and Ventures Group Seed Fund, with participation from Cultivate (MD), Alumni Venture Group, and Mountain State Capital, among others. Nanochon intends to use the funds to initiate its first in human clinical trials in the US in 2024, deepen research and development efforts, expand the company’s patent profile and grow its team. “We’re thrilled to close our funding round and begin our clinical program,” says Ben Holmes, CEO and co-founder. “Securing this funding is one step closer towards achieving Nanochon’s goals of eliminating the need for knee replacements, and greatly shifting the paradigm of arthritic joint care.” Nanochon will initiate a phase I trial in the US this year for its patented knee implant Chondrograft™. The device requires only minimally invasive surgery to regrow damaged cartilag

Biocytogen Enters Into Evaluation and Potential Licensing Agreement With BioCopy For TCR-mimic Antibodies6.5.2024 17:00:00 EEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotechnology company focused on the discovery of novel antibody-based therapeutics, today announced a TCR-mimic antibody evaluation and potential licensing agreement with BioCopy AG (“BioCopy”), a research-based biotechnology company headquartered in Basel, Switzerland. The agreement grants BioCopy access to fully human TCR-mimic antibodies targeting an intracellular antigen generated by Biocytogen’s proprietary RenTCR-mimicTM mice. BioCopy will conduct an evaluation and retain the option to license these antibodies for the development of novel cancer therapies. “We are glad to provide BioCopy with our TCR-mimic antibodies,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “Our in vivo matured TCR-mimic antibodies demonstrated favorable affinity and excellent specificity. Combined with BioCopy’s expertise in TCR-mimic antibody screening and engager development, we are optimistic that our collabo

NanoTemper Brings Spectral Shift Technology to the Protein Production Market With Andromeda X, Enabling Biopharma and CROs to Increase Efficiency of Expression Screening for Recombinant Protein Targets6.5.2024 16:17:00 EEST | Press release

NanoTemper Technologies, well known for creating biophysical tools that accelerate the work of drug discovery researchers, brings their groundbreaking Spectral Shift technology to the protein production market with the release of Andromeda X, an instrument that determines optimal expression alongside thermal stability of recombinant proteins in crude lysates. Andromeda X increases the efficiency of protein production teams at Biopharma and CROs, who now have the ability to optimize purification schemes for challenging, low-yield targets much faster, and with unprecedented insights on thermal stability during expression screening. “At NanoTemper, our vision of creating a world where every disease is treatable starts here, in early drug development. Without high-quality drug targets or protein therapeutics, researchers cannot realize this vision. So, we’ve adapted our reliable and trusted optics systems to provide valuable insights for those working to express and purify these critical t

Yubico’s Key Product Innovations Empower Enterprise Security and Phishing-Resistant Passwordless Authentication at Scale6.5.2024 16:00:00 EEST | Press release

Today Yubico (NASDAQ: YUBICO), the leading provider of hardware authentication security keys, announced the upcoming release of YubiKey 5.7 firmware for the YubiKey 5 Series, Security Key Series and Security Key Series - Enterprise Edition. With a focus on enterprise needs, these updates reinforce Yubico’s commitment to providing secure, simple, and scalable authentication solutions. Security keys with firmware 5.7 will be available to purchase in late May 2024, offering enhanced features such as improved PIN complexity, enterprise attestation, and expanded passkey credentials storage. These updates empower organizations to adopt passwordless-first, modern authentication, fostering phishing-resistant users worldwide. As part of Yubico’s goal of helping enterprises raise the bar for security with greater flexibility, the company also announced the availability of Yubico Authenticator 7 which will support the upcoming YubiKey 5.7 features. “Organizations are continuing to face a surge in

ATMECS Global Accelerates AI Innovation by Joining the NVIDIA Partner Network as Solution Advisor Consultant.6.5.2024 16:00:00 EEST | Press release

ATMECS Global, renowned for its prowess in digital transformation and engineering solutions, proudly announces that it has joined the NVIDIA Partner Network as a Solution Advisor Consultant. The milestone marks a pivotal step in ATMECS’s journey to redefine the AI and ML landscape, amplifying its commitment to innovation and excellence in delivering next-generation AI solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240506918366/en/ Lori Banas-Chief AI/ML Officer (Photo: Business Wire) ATMECS will support customers in building and deploying a broad range of NVIDIA-powered solutions — including through the use of the NVIDIA Omniverse development platform for industrial digital twins, generative AI with NVIDIA NIM inference microservices and the NVIDIA AI Enterprise platform for cloud and on-premises deployments, as well as the NVIDIA Jetson platform for accelerated edge AI and robotics. Lori Banas, Chief AI/ML Office

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye